(Q33844879)

29 July 2017

title

Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial (English)

1 reference

29 July 2017

1 reference

K Vaughan

1

1 reference

29 July 2017

N McConaghy

series ordinal

2

1 reference

29 July 2017

publication date

1 February 1999

1 reference

Australian and New Zealand Journal of Psychiatry

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

84-88

1 reference

The relationship between relative's Expressed Emotion and schizophrenic relapse: an Australian replication.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.1999.00527.X

The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.1999.00527.X

Orthomolecular Psychiatry: Varying the concentrations of substances normally present in the human body may control mental disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.1999.00527.X

A search for responders to niacin supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.1999.00527.X

Nicotinic Acid in the Treatment of Schizophrenias: Canadian Mental Health Association Collaborative Study Progress Report II

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.1999.00527.X

Nicotinic acid therapy in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.1999.00527.X

Psychosocial functioning and subjective experience in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.1999.00527.X

10.1046/J.1440-1614.1999.00527.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference